Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 118.03% | 43.97% | 34.07% | 38.51% | -91.72% |
| Total Depreciation and Amortization | 100.84% | 50.00% | 250.00% | -- | -- |
| Total Amortization of Deferred Charges | -42.86% | 0.00% | 0.00% | 0.00% | 75.02% |
| Total Other Non-Cash Items | -363.95% | -102.13% | -97.31% | -102.17% | 683.87% |
| Change in Net Operating Assets | -10.20% | 319.30% | 2,063.41% | 3.56% | 1,105.13% |
| Cash from Operations | -11.33% | 14.77% | 6.39% | -27.16% | -4.20% |
| Capital Expenditure | 100.00% | 99.66% | 95.37% | 93.48% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 0.00% | -93.94% | 104.11% | 100.29% |
| Cash from Investing | 101.03% | 100.34% | 95.56% | 95.70% | 71.41% |
| Total Debt Issued | -42.18% | -19.35% | -12.86% | 12.49% | -14.15% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 75.28% | -19.35% | -12.86% | 12.49% | -14.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,367.00% | 99.22% | 103.13% | 97.73% | 1,328.57% |
